Kevin DeGeeter
Stock Analyst at Ladenburg Thalmann & Co.
(4.71)
# 755
Out of 4,673 analysts
431
Total ratings
38.6%
Success rate
19%
Average return
Main Sectors:
Stocks Rated by Kevin DeGeeter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLRB Cellectar Biosciences | Reiterated: Buy | $10 | $2.59 | +286.10% | 14 | Aug 14, 2026 | |
| ELTX Elicio Therapeutics | Initiated Coverage: Buy | $20 → $12 | $3.04 | +294.74% | 2 | Jun 18, 2026 | |
| TRAW Traws Pharma | Downgraded: Hold | n/a | $0.53 | - | 2 | Jun 15, 2026 | |
| URGN UroGen Pharma | Initiated Coverage: Buy | $43 | $46.86 | -8.24% | 1 | May 11, 2026 | |
| DCOY Decoy Therapeutics | Initiated Coverage: Buy | $2.5 | $3.20 | -21.88% | 1 | Jan 23, 2026 | |
| ORIC ORIC Pharmaceuticals | Maintained: Buy | $15 | $14.20 | +5.63% | 21 | Nov 14, 2025 | |
| CRDF Cardiff Oncology | Reiterated: Buy | $19 | $0.8801 | +2,058.85% | 2 | Nov 10, 2025 | |
| NXTC NextCure | Upgraded: Buy | $18 | $6.29 | +186.17% | 1 | Nov 7, 2025 | |
| OPK OPKO Health | Maintained: Buy | $5.2 → $3 | $1.48 | +102.70% | 10 | Oct 30, 2025 | |
| NVCR NovoCure | Initiated Coverage: Buy | $98 → $30 | $17.10 | n/a | 13 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 → $59 | $59.74 | n/a | 18 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $5.81 | n/a | 1 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $37 | $6.09 | n/a | 9 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $7 | $0.000001 | n/a | 13 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $17 | $2.14 | n/a | 2 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $24 | $18.38 | n/a | 21 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $141 → $125 | $19.90 | n/a | 20 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.20 | n/a | 19 | Dec 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 → $5 | $0.000001 | n/a | 8 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.22 | n/a | 23 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $0.1545 | n/a | 1 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $13.21 | n/a | 16 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $0.593 | n/a | 18 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $3.31 | n/a | 6 | Jul 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $42.68 | n/a | 24 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $39.67 | n/a | 20 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $32.00 | n/a | 6 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.5 | $0.000001 | n/a | 21 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $5.09 | n/a | 1 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $0.8651 | n/a | 1 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.06 | n/a | 13 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.51 | n/a | 9 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.52 | n/a | 7 | Nov 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.94 | n/a | 22 | Jun 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.91 | n/a | 12 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $1.08 | n/a | 7 | May 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.0001 | n/a | 1 | Jul 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $7.5 | $9.84 | n/a | 2 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $17.00 | n/a | 2 | Apr 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.515 | n/a | 2 | Feb 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $3.20 | n/a | 6 | Feb 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $1.67 | n/a | 1 | Jan 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $37.34 | n/a | 5 | Dec 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 3 | Nov 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $45 | $0.63 | n/a | 1 | Oct 31, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $75 | $127.81 | n/a | 9 | Oct 30, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $1.58 | n/a | 4 | Aug 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $121 | $439.33 | n/a | 2 | Apr 4, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $9.55 | n/a | 1 | Feb 28, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $146.12 | n/a | 2 | Jan 26, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 → $3 | $0.0001 | n/a | 2 | Nov 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $0.0008 | n/a | 1 | Oct 1, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.75 → $2.75 | $0.000001 | n/a | 2 | Aug 8, 2013 |
Cellectar Biosciences
Aug 14, 2026
Reiterated: Buy
Price Target: $10
Current: $2.59
Upside: +286.10%
Elicio Therapeutics
Jun 18, 2026
Initiated Coverage: Buy
Price Target: $20 → $12
Current: $3.04
Upside: +294.74%
Traws Pharma
Jun 15, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.53
Upside: -
UroGen Pharma
May 11, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $46.86
Upside: -8.24%
Decoy Therapeutics
Jan 23, 2026
Initiated Coverage: Buy
Price Target: $2.5
Current: $3.20
Upside: -21.88%
ORIC Pharmaceuticals
Nov 14, 2025
Maintained: Buy
Price Target: $15
Current: $14.20
Upside: +5.63%
Cardiff Oncology
Nov 10, 2025
Reiterated: Buy
Price Target: $19
Current: $0.8801
Upside: +2,058.85%
NextCure
Nov 7, 2025
Upgraded: Buy
Price Target: $18
Current: $6.29
Upside: +186.17%
OPKO Health
Oct 30, 2025
Maintained: Buy
Price Target: $5.2 → $3
Current: $1.48
Upside: +102.70%
NovoCure
Jul 8, 2025
Initiated Coverage: Buy
Price Target: $98 → $30
Current: $17.10
Upside: n/a
Apr 19, 2022
Maintained: Buy
Price Target: $63 → $59
Current: $59.74
Upside: n/a
Apr 19, 2022
Initiated Coverage: Buy
Price Target: $22
Current: $5.81
Upside: n/a
Apr 1, 2022
Maintained: Buy
Price Target: $45 → $37
Current: $6.09
Upside: n/a
Mar 30, 2022
Maintained: Buy
Price Target: $9 → $7
Current: $0.000001
Upside: n/a
Mar 30, 2022
Maintained: Buy
Price Target: $19 → $17
Current: $2.14
Upside: n/a
Feb 25, 2022
Maintained: Buy
Price Target: $30 → $24
Current: $18.38
Upside: n/a
Jan 25, 2022
Maintained: Buy
Price Target: $141 → $125
Current: $19.90
Upside: n/a
Dec 27, 2021
Maintained: Buy
Price Target: $14
Current: $1.20
Upside: n/a
Nov 16, 2021
Reiterated: Buy
Price Target: $5.5 → $5
Current: $0.000001
Upside: n/a
Oct 1, 2021
Downgraded: Hold
Price Target: n/a
Current: $1.22
Upside: n/a
Sep 20, 2021
Initiated Coverage: Buy
Price Target: $30
Current: $0.1545
Upside: n/a
Jul 20, 2021
Maintained: Buy
Price Target: $7
Current: $13.21
Upside: n/a
Jul 13, 2021
Maintained: Buy
Price Target: $18
Current: $0.593
Upside: n/a
Jul 8, 2021
Maintained: Buy
Price Target: $18
Current: $3.31
Upside: n/a
Jun 30, 2021
Reiterated: Hold
Price Target: n/a
Current: $42.68
Upside: n/a
Jun 28, 2021
Maintained: Buy
Price Target: $25
Current: $39.67
Upside: n/a
Jun 28, 2021
Downgraded: Hold
Price Target: n/a
Current: $32.00
Upside: n/a
Jun 16, 2021
Maintained: Buy
Price Target: $5.5
Current: $0.000001
Upside: n/a
May 26, 2021
Initiated Coverage: Buy
Price Target: $25
Current: $5.09
Upside: n/a
Apr 29, 2021
Initiated Coverage: Buy
Price Target: $17
Current: $0.8651
Upside: n/a
Mar 4, 2021
Rated: Hold
Price Target: n/a
Current: $10.06
Upside: n/a
Mar 4, 2021
Rated: Hold
Price Target: n/a
Current: $3.51
Upside: n/a
Nov 25, 2020
Rated: Hold
Price Target: n/a
Current: $1.52
Upside: n/a
Jun 15, 2020
Rated: Hold
Price Target: n/a
Current: $8.94
Upside: n/a
Feb 24, 2020
Rated: Hold
Price Target: n/a
Current: $6.91
Upside: n/a
May 9, 2019
Rated: Buy
Price Target: $3
Current: $1.08
Upside: n/a
Jul 10, 2018
Initiated Coverage: Buy
Price Target: $3
Current: $0.0001
Upside: n/a
Jun 13, 2018
Reiterated: Buy
Price Target: $13 → $7.5
Current: $9.84
Upside: n/a
Apr 10, 2017
Maintained: Buy
Price Target: $13
Current: $17.00
Upside: n/a
Feb 14, 2017
Downgraded: Hold
Price Target: n/a
Current: $0.515
Upside: n/a
Feb 8, 2017
Upgraded: Hold
Price Target: n/a
Current: $3.20
Upside: n/a
Jan 4, 2017
Upgraded: Buy
Price Target: n/a
Current: $1.67
Upside: n/a
Dec 15, 2014
Rated: Hold
Price Target: n/a
Current: $37.34
Upside: n/a
Nov 13, 2014
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Oct 31, 2014
Rated: Sell
Price Target: $45
Current: $0.63
Upside: n/a
Oct 30, 2014
Rated: Buy
Price Target: $75
Current: $127.81
Upside: n/a
Aug 7, 2014
Rated: Buy
Price Target: $3
Current: $1.58
Upside: n/a
Apr 4, 2014
Rated: Hold
Price Target: $121
Current: $439.33
Upside: n/a
Feb 28, 2014
Initiated Coverage: Hold
Price Target: n/a
Current: $9.55
Upside: n/a
Jan 26, 2014
Rated: Buy
Price Target: $86
Current: $146.12
Upside: n/a
Nov 7, 2013
Reiterated: Buy
Price Target: $7.5 → $3
Current: $0.0001
Upside: n/a
Oct 1, 2013
Upgraded: Buy
Price Target: n/a
Current: $0.0008
Upside: n/a
Aug 8, 2013
Reiterated: Buy
Price Target: $1.75 → $2.75
Current: $0.000001
Upside: n/a